相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials
Wei Zheng et al.
PHARMACOPSYCHIATRY (2019)
A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
Marie C. Bradley et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Meta-Analyses in Child and Adolescent Psychiatry: Getting Closer to Clinical Practice
Samuele Cortese
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2018)
Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies
Kyle J. Burghardt et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study
Yu-Tang Chang et al.
TRANSLATIONAL ONCOLOGY (2018)
Mechanisms of metformin action: In and out of the gut
Takahiro Minamii et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study
Patrice Simard et al.
ANNALS OF PHARMACOTHERAPY (2018)
Screening for Obesity and Intervention for Weight Management in Children and Adolescents Evidence Report and Systematic Review for the US Preventive Services Task Force
Elizabeth A. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Antipsychotic-Induced Weight Gain and Metformin
John T. Walkup et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2017)
Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis
Valerie D. Nolt et al.
PEDIATRIC DRUGS (2017)
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Marco Solmi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis
Johanna Taylor et al.
PLOS ONE (2017)
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
Madhubhashinee Dayabandara et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder
Logan K. Wink et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2017)
Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
Varuni Asanka de Silva et al.
BMC PSYCHIATRY (2016)
Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials
R-R Wu et al.
MOLECULAR PSYCHIATRY (2016)
Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2016)
Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder A Randomized Clinical Trial
Evdokia Anagnostou et al.
JAMA PSYCHIATRY (2016)
Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
Dan J. Siskind et al.
PLOS ONE (2016)
Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment Meta-Analysis of Randomized Placebo-Controlled Trials
Wei Zheng et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Maarten Bak et al.
PLOS ONE (2014)
The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric Units in Poland
Jan Jaracz et al.
PHARMACOLOGICAL REPORTS (2014)
Systematic Review of the Benefits and Risks of Metformin in Treating Obesity in Children Aged 18 Years and Younger
Marian S. McDonagh et al.
JAMA PEDIATRICS (2014)
Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments
Edmund J. S. Sonuga-Barke et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes The TODAY experience
Neil H. White et al.
DIABETES CARE (2013)
Pharmacoepidemiology of Antipsychotic Use in Youth with ADHD: Trends and Clinical Implications
Michael L. Birnbaum et al.
CURRENT PSYCHIATRY REPORTS (2013)
Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
Noor B. Almandil et al.
PEDIATRIC DRUGS (2013)
National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics
Mark Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Antipsychotic polypharmacy in a regional health service: a population-based study
Miguel Bernardo et al.
BMC PSYCHIATRY (2012)
The heart of the matter: cardiometabolic care in youth with psychosis
Jackie Curtis et al.
EARLY INTERVENTION IN PSYCHIATRY (2012)
National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom
Philip Prah et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs
Mehrul Hasnain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Assessment and management of obesity in childhood and adolescence
Louise A. Baur et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease
Amir Tirosh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
Markus Juonala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation Review of the Literature and Clinical Suggestions
Mehrul Hasnain et al.
CNS DRUGS (2010)
Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
Lawrence Maayan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Tourette's Syndrome
Roger Kurlan
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication
Lauren Shin et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics follow-up study
John A. Morrison et al.
PEDIATRICS (2007)
Characterisation of morbidity in a UK, hospital based, obesity clinic
MA Sabin et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Risperidone in children with autism and serious behavioral problems
JT McCracken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Metformin for weight loss in pediatric patients taking psychotropic drugs
JA Morrison et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
分享论文
